348 related articles for article (PubMed ID: 15657072)
1. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
Maddison P; Kiely P; Kirkham B; Lawson T; Moots R; Proudfoot D; Reece R; Scott D; Sword R; Taggart A; Thwaites C; Williams E
Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072
[TBL] [Abstract][Full Text] [Related]
2. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial.
Poór G; Strand V;
Rheumatology (Oxford); 2004 Jun; 43(6):744-9. PubMed ID: 15026583
[TBL] [Abstract][Full Text] [Related]
4. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
5. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
Wolfe F; Michaud K; Stephenson B; Doyle J
J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
Smolen JS; Emery P; Kalden JR; Van Riel PL; Dougados M; Strand CV; Breedveld FC
J Rheumatol Suppl; 2004 Jun; 71():13-20. PubMed ID: 15170903
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
Goldenberg MM
Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
[TBL] [Abstract][Full Text] [Related]
10. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
Flendrie M; Creemers MC; Welsing PM; van Riel PL
Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
[TBL] [Abstract][Full Text] [Related]
11. Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis.
Kalden JR; Antoni C; Alvaro-Gracia JM; Combe B; Emery P; Kremer JM; Strand CV; Van Riel P; Smolen JS
J Rheumatol; 2005 Aug; 32(8):1620-31. PubMed ID: 16078347
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide: new indication. In psoriatic rheumatism: too many risks, too little efficacy.
Prescrire Int; 2005 Aug; 14(78):123-6. PubMed ID: 16106593
[TBL] [Abstract][Full Text] [Related]
13. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Maetzel A; Strand V; Tugwell P; Wells G; Bombardier C
Arthritis Rheum; 2002 Dec; 47(6):655-61. PubMed ID: 12522841
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
16. Lefunomide in combination therapy.
Kalden JR; Smolen JS; Emery P; van Riel PL; Dougados M; Strand CV; Breedveld FC
J Rheumatol Suppl; 2004 Jun; 71():25-30. PubMed ID: 15170905
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide for the treatment of rheumatoid arthritis.
Olsen NJ; Strand V; Kremer JM
Bull Rheum Dis; 1999; 48(8):1-4. PubMed ID: 10628065
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide.
Cohen SB; Iqbal I
Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide: a manageable safety profile.
van Riel PL; Smolen JS; Emery P; Kalden JR; Dougados M; Strand CV; Breedveld FC
J Rheumatol Suppl; 2004 Jun; 71():21-4. PubMed ID: 15170904
[TBL] [Abstract][Full Text] [Related]
20. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]